Xoma | XOMA - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
AbbVie USD 3.59B 28.65B 2025-12
Agenus USD 71.08M 11.9M 2026-03
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Ardelyx USD 28.2M 8.96M 2026-03
aTyr Pharma USD 2.76M 52.32M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Celldex Therapeutics USD 10.36M 9.18M 2026-03
Curis USD 5.61M 1.52M 2025-12
Eli Lilly USD 5.03B 350M 2026-03
Emergent BioSolutions USD 112.2M 500K 2023-12
Incyte USD 228.62M 1.41B 2026-03
MacroGenics USD 4.29M 500K 2026-03
Novartis USD 4.32B 134M 2026-03
Novartis USD 4.46B 99M 2025-12
Pfizer USD 4.51B 734M 2026-03
Prothena USD 4.3M 1.58M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Xoma USD 2.65M 1.52M 2025-09